197 related articles for article (PubMed ID: 18479962)
41. Use of genomic analysis of varicella-zoster virus to investigate suspected varicella-zoster transmission within a renal unit.
Molyneaux PJ; Parker S; Khan IH; Millar CG; Breuer J
J Clin Virol; 2006 May; 36(1):76-8. PubMed ID: 16545596
[TBL] [Abstract][Full Text] [Related]
42. Cycling probe technology to quantify and discriminate between wild-type varicella-zoster virus and Oka vaccine strains.
Ihira M; Higashimoto Y; Kawamura Y; Sugata K; Ohashi M; Asano Y; Yoshikawa T
J Virol Methods; 2013 Nov; 193(2):308-13. PubMed ID: 23820238
[TBL] [Abstract][Full Text] [Related]
43. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
44. An unusual case of multi-recurrent herpes zoster (Hz): a case report.
Bostikova V; Salavec M; Smetana J; Chlibek R; Kosina P; Prasil P; Plisek S; Splino M; Bostik P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):397-401. PubMed ID: 22336654
[TBL] [Abstract][Full Text] [Related]
45. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.
Cohrs RJ; Gilden DH; Gomi Y; Yamanishi K; Cohen JI
J Virol; 2006 Mar; 80(5):2076-82. PubMed ID: 16474115
[TBL] [Abstract][Full Text] [Related]
46. Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus.
Fukuda Y; Suzuki T; Iwata KI; Haruta K; Yamaguchi M; Torii Y; Narita A; Muramatsu H; Takahashi Y; Kawada JI
Vaccine; 2024 Apr; 42(11):2927-2932. PubMed ID: 38548526
[TBL] [Abstract][Full Text] [Related]
47. Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction.
Yoshida M; Tamura T; Hiruma M
J Med Virol; 1999 May; 58(1):76-8. PubMed ID: 10223550
[TBL] [Abstract][Full Text] [Related]
48. Varicella zoster virus: out of Africa and into the research laboratory.
Grose C
Herpes; 2006 Aug; 13(2):32-6. PubMed ID: 16895651
[TBL] [Abstract][Full Text] [Related]
49. A cost-effective high-resolution melting approach using the EvaGreen dye for DNA polymorphism detection and genotyping in plants.
Li YD; Chu ZZ; Liu XG; Jing HC; Liu YG; Hao DY
J Integr Plant Biol; 2010 Dec; 52(12):1036-42. PubMed ID: 21106003
[TBL] [Abstract][Full Text] [Related]
50. Molecular diagnosis of zoster post varicella vaccination.
Sauerbrei A; Uebe B; Wutzler P
J Clin Virol; 2003 Jul; 27(2):190-9. PubMed ID: 12829041
[TBL] [Abstract][Full Text] [Related]
51. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
52. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.
Loparev VN; Gonzalez A; Deleon-Carnes M; Tipples G; Fickenscher H; Torfason EG; Schmid DS
J Virol; 2004 Aug; 78(15):8349-58. PubMed ID: 15254207
[TBL] [Abstract][Full Text] [Related]
53. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
54. A real-time PCR assay for the detection of varicella-zoster virus DNA and differentiation of vaccine, wild-type and control strains.
Tipples GA; Safronetz D; Gray M
J Virol Methods; 2003 Nov; 113(2):113-6. PubMed ID: 14553897
[TBL] [Abstract][Full Text] [Related]
55. Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.
LaRussa P; Steinberg S; Arvin A; Dwyer D; Burgess M; Menegus M; Rekrut K; Yamanishi K; Gershon A
J Infect Dis; 1998 Nov; 178 Suppl 1():S64-6. PubMed ID: 9852977
[TBL] [Abstract][Full Text] [Related]
56. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI.
Hayakawa Y; Yamamoto T; Yamanishi K; Takahashi M
J Gen Virol; 1986 Sep; 67 ( Pt 9)():1817-29. PubMed ID: 3018125
[TBL] [Abstract][Full Text] [Related]
57. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR.
Campsall PA; Au NH; Prendiville JS; Speert DP; Tan R; Thomas EE
J Clin Microbiol; 2004 Apr; 42(4):1409-13. PubMed ID: 15070981
[TBL] [Abstract][Full Text] [Related]
58. Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination.
Norberg P; Liljeqvist JA; Bergström T; Sammons S; Schmid DS; Loparev VN
J Virol; 2006 Oct; 80(19):9569-76. PubMed ID: 16973560
[TBL] [Abstract][Full Text] [Related]
59. Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus.
Springfeld C; Sauerbrei A; Filusch A; Konstandin M; Hartschuh W; Sauer P; Encke J; Stremmel W; Schnitzler P
J Clin Virol; 2009 Jan; 44(1):70-3. PubMed ID: 19056312
[TBL] [Abstract][Full Text] [Related]
60. Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms.
Jin L; Xu S; Maple PAC; Xu W; Brown KE
Epidemiol Infect; 2017 Sep; 145(12):2618-2625. PubMed ID: 28748773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
